About Cynosure

We are leaders, innovators, developers, and best-in-class creators of energy-based aesthetic and medical treatment systems. Cynosure develops and manufactures a diverse range of leading treatment applications for hair removal, skin revitalisation, scar reduction, gynecological health, body contouring, and more. Our innovative products are used worldwide by practitioners, physicians, and aesthetic business owners to help enhance their offerings while providing the latest treatments to patients. Contact our team about how Cynosure can help you grow and succeed.


About AMICO Group – Cynosure distributor for the Middle East

AMICO Group, established in 1984 in Saudi Arabia, has emerged as a leading medical device distributor in the MENA region. With a strong presence in 12 countries, the company specializes in providing advanced medical technologies in various areas such as dermatology, ophthalmology, orthopedics, neurosurgery, ENT, optics, spinal surgery, pharmaceuticals and imaging.

What sets AMICO Group apart is its commitment to providing not just the latest medical technologies, but also extensive medical education and training to specialists. This ensures that healthcare professionals have access to the latest innovations and can provide the best possible care to their patients. With its focus on technology, education, and innovation, AMICO Group is a trusted partner for healthcare providers in the MENA region.

Why Cynosure?

Always innovating. Always looking ahead.

With our comprehensive array of laser and RF technologies as well as technical, clinical and support services, Cynosure helps providers maximise growth and opportunities. While providing patients with the cutting edge treatments and services they deserve.

Leading the industry. Forging new paths.

Cynosure continues to be an industry leader in energy-based systems representing advanced levels of solid state liquid and semiconductor technologies. We are constantly looking forward to stay one step ahead of the industry while bringing patients and providers the latest in treatments.